Protalix BioTherapeutics
PLX
#8899
Rank
โ‚น12.68 B
Marketcap
โ‚น157.67
Share price
1.16%
Change (1 day)
5.81%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): -โ‚น3.42

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is -โ‚น3.60. In 2024 the company made an earnings per share (EPS) of โ‚น3.60 a decrease over its 2023 EPS that were of โ‚น10.81.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น3.42-194.93%
2024โ‚น3.60-66.67%
2023โ‚น10.81-138.71%
2022-โ‚น27.93-50%
2021-โ‚น55.86181.82%
2020-โ‚น19.82-82.11%
2019-โ‚น110.82-31.67%
2018-โ‚น162.18-72.31%
2017-โ‚น585.65124.14%
2016-โ‚น261.29-147.54%
2015โ‚น549.61-290.63%
2014-โ‚น288.326.67%
2013-โ‚น270.30130.77%
2012-โ‚น117.13-69.77%
2011-โ‚น387.4319.44%
2010-โ‚น324.36-12.2%
2009-โ‚น369.4136.67%
2008-โ‚น270.30-37.5%
2007-โ‚น432.4850%
2006-โ‚น288.323.23%
2005-โ‚น279.31138.46%
2004-โ‚น117.13-74%
2003-โ‚น450.50-0%
2002-โ‚น450.50-50%
2001-โ‚น901.00233.33%
2000-โ‚น270.30-84.21%
1999-โ‚น1,712-24%
1998-โ‚น2,252-600%
1997โ‚น450.50-16.67%
1996โ‚น540.60

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amicus Therapeutics
FOLD
-โ‚น9.91 175.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น388.33-10,875.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น154.97-4,400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น56.76-1,675.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel